Nicola Maria Fiore

I study disclosure and healthcare, with a focus on how transparency and information design affect markets and policy. My goal is to understand how better disclosure practices can lead to fairer, more efficient, and more accountable systems.

I will be on the job market in Fall 2025 and attend the EAA Talent Workshop.  

JOB MARKET PAPER

Can Drug Pricing Transparency Reduce Drug Costs?

Persistently high prescription drug costs and opaque contracting in U.S. pharmaceutical markets have prompted regulators to adopt transparency mandates, though theory is ambiguous on whether disclosure enhances competition or distorts pricing. I study whether greater transparency reduces patient costs. Using a sample of cardiovascular drugs, I find no evidence that rebate disclosure lowers prices. Even among plans facing tighter profit constraints—where incentives to pass through savings are strongest—and those with greater bargaining power, there is no measurable response. These findings suggest transparency mandates alone may be insufficient to curb drug spending.
 
 

WORKING PAPERS

• Fiore, N. M, "Can Drug Pricing Transparency Reduce Drug Costs?"
• Fiore, N.M., Nagler, F., Martin, T. "Fiscal Constraints, Disaster Vulnerability, and Corporate Investment Decisions."
• Fiore, N. M., Martens, T., and Zhao, W. "In the Eyes of Beholders: Evidence from Redistricting."

WORK IN PROGRESS

• Fiore, N. M., Imperatore, C., Pope, P., and Pundrich, G. "The Quality and Impact of Fairness Opinions."